Novartis faces drug pipeline test with valuation premium in focus
By Bhanvi Satija LONDON, July 20 (Reuters) - Novartis investors will look beyond Tuesday's quarterly...
20th July, 2026
By Bhanvi Satija LONDON, July 20 (Reuters) - Novartis investors will look beyond Tuesday's quarterly...
20th July, 2026
By Toby Sterling and Nathan Vifflin AMSTERDAM, July 20 (Reuters) - The global artificial intelligenc...
20th July, 2026
By Ozan Ergenay and Bartosz Dabrowski July 20 (Reuters) - European chemical companies are expected t...
20th July, 2026
July 17 (Reuters) - Railpen, the largest shareholder in Britain's IP Group, said on Friday it has ma...
17th July, 2026
July 17 (Reuters) - Global equity funds attracted inflows for an eighth consecutive week through Jul...
17th July, 2026
By Jamie McGeever ORLANDO, Florida, July 16 (Reuters) - A shakeout in U.S. semiconductor stocks tank...
16th July, 2026
July 16 (Reuters) - Prediction market platform Kalshi will start taking bets on the outcomes of clin...
16th July, 2026
July 15 (Reuters) - London's FTSE 100 slipped on Wednesday as investors remained cautious over escal...
15th July, 2026
July 14 (Reuters) - Saba Capital Management has become the largest shareholder in Workspace Group, s...
14th July, 2026
By Hannah Lang NEW YORK, July 13 (Reuters) - A move by Michael Saylor's bitcoin stockpiling company...
13th July, 2026
By Saqib Iqbal Ahmed and Laura Matthews NEW YORK, July 13 (Reuters) - A solid U.S. dollar rally in 2...
13th July, 2026
By Tim Hepher and Karen Lema PARIS/MANILA, July 10 (Reuters) - Philippine Airlines (PAL) is poised t...
10th July, 2026